ANTAGONISTS OF VITRONECTIN RECEPTORS

Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety.

Saved in:
Bibliographic Details
Main Authors BONDINELL WILLIAM, KEENAN RICHARD MCCULLOCH, NGUYEN THOMAS, KWON CHET, TAKATA DENNIS T, ALI FADIA EL-FAHAIL, MILLER WILLIAM HENRY, LAGO M.AMPARO, HUFFMAN WILLIAM FRANCIS
Format Patent
LanguageEnglish
Published 26.05.1997
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety.
Bibliography:Application Number: PL19950318199